Increased urinary dopamine excretion in Young patients with essential hypertension

I. Saito, S. Itsuji, E. Takeshita, H. Kawabe, M. Nishino, H. Wainai, C. Hasegawa, T. Saruta, S. Nagano, T. Sekihara

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The evidence that some older patients with essential hypertension have low urinary dopamine excretion has brought into question the levels of urinary dopamine and plasma dopa, the major source of urinary dopamine, in young patients with essential hypertension. Twentyfour-hour urine sodium, creatinine, dopamine and noradrenaline and plasma dopa were evaluated in 48 patients with essential hypertension aged 18 to 27 years and 25 normotensive subjects. In comparison with age-matched normotensive subjects, the hypertensive patients had higher urinary dopamine (1920 ± 80 vs 1520 ± 130 nmol/day, p < 0.01) and noradrenaline (216 ± 11 vs 179 ± 12 nmol/day, p < 0.05) excretion. There was a significant correlation between urinary dopamine and noradrenaline excretion. There was no difference in plasma dopa levels between normotensive and hypertensive subjects. These results suggest that the elevated conversion of dopa to dopamine in the kidney is leading to increased urinary dopamine excretion in young patients with essential hypertension.

Original languageEnglish
Pages (from-to)29-39
Number of pages11
JournalClinical and Experimental Hypertension
Volume16
Issue number1
DOIs
Publication statusPublished - 1994

Fingerprint

Dopamine
Dihydroxyphenylalanine
Norepinephrine
Essential Hypertension
Creatinine
Sodium
Urine
Kidney

Keywords

  • Dopa
  • Dopamine
  • Essential Hypertension

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology

Cite this

Saito, I., Itsuji, S., Takeshita, E., Kawabe, H., Nishino, M., Wainai, H., ... Sekihara, T. (1994). Increased urinary dopamine excretion in Young patients with essential hypertension. Clinical and Experimental Hypertension, 16(1), 29-39. https://doi.org/10.3109/10641969409068582

Increased urinary dopamine excretion in Young patients with essential hypertension. / Saito, I.; Itsuji, S.; Takeshita, E.; Kawabe, H.; Nishino, M.; Wainai, H.; Hasegawa, C.; Saruta, T.; Nagano, S.; Sekihara, T.

In: Clinical and Experimental Hypertension, Vol. 16, No. 1, 1994, p. 29-39.

Research output: Contribution to journalArticle

Saito, I, Itsuji, S, Takeshita, E, Kawabe, H, Nishino, M, Wainai, H, Hasegawa, C, Saruta, T, Nagano, S & Sekihara, T 1994, 'Increased urinary dopamine excretion in Young patients with essential hypertension', Clinical and Experimental Hypertension, vol. 16, no. 1, pp. 29-39. https://doi.org/10.3109/10641969409068582
Saito, I. ; Itsuji, S. ; Takeshita, E. ; Kawabe, H. ; Nishino, M. ; Wainai, H. ; Hasegawa, C. ; Saruta, T. ; Nagano, S. ; Sekihara, T. / Increased urinary dopamine excretion in Young patients with essential hypertension. In: Clinical and Experimental Hypertension. 1994 ; Vol. 16, No. 1. pp. 29-39.
@article{a675f941e0494eedb64fa7cb3a1eee07,
title = "Increased urinary dopamine excretion in Young patients with essential hypertension",
abstract = "The evidence that some older patients with essential hypertension have low urinary dopamine excretion has brought into question the levels of urinary dopamine and plasma dopa, the major source of urinary dopamine, in young patients with essential hypertension. Twentyfour-hour urine sodium, creatinine, dopamine and noradrenaline and plasma dopa were evaluated in 48 patients with essential hypertension aged 18 to 27 years and 25 normotensive subjects. In comparison with age-matched normotensive subjects, the hypertensive patients had higher urinary dopamine (1920 ± 80 vs 1520 ± 130 nmol/day, p < 0.01) and noradrenaline (216 ± 11 vs 179 ± 12 nmol/day, p < 0.05) excretion. There was a significant correlation between urinary dopamine and noradrenaline excretion. There was no difference in plasma dopa levels between normotensive and hypertensive subjects. These results suggest that the elevated conversion of dopa to dopamine in the kidney is leading to increased urinary dopamine excretion in young patients with essential hypertension.",
keywords = "Dopa, Dopamine, Essential Hypertension",
author = "I. Saito and S. Itsuji and E. Takeshita and H. Kawabe and M. Nishino and H. Wainai and C. Hasegawa and T. Saruta and S. Nagano and T. Sekihara",
year = "1994",
doi = "10.3109/10641969409068582",
language = "English",
volume = "16",
pages = "29--39",
journal = "Clinical and Experimental Hypertension",
issn = "1064-1963",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Increased urinary dopamine excretion in Young patients with essential hypertension

AU - Saito, I.

AU - Itsuji, S.

AU - Takeshita, E.

AU - Kawabe, H.

AU - Nishino, M.

AU - Wainai, H.

AU - Hasegawa, C.

AU - Saruta, T.

AU - Nagano, S.

AU - Sekihara, T.

PY - 1994

Y1 - 1994

N2 - The evidence that some older patients with essential hypertension have low urinary dopamine excretion has brought into question the levels of urinary dopamine and plasma dopa, the major source of urinary dopamine, in young patients with essential hypertension. Twentyfour-hour urine sodium, creatinine, dopamine and noradrenaline and plasma dopa were evaluated in 48 patients with essential hypertension aged 18 to 27 years and 25 normotensive subjects. In comparison with age-matched normotensive subjects, the hypertensive patients had higher urinary dopamine (1920 ± 80 vs 1520 ± 130 nmol/day, p < 0.01) and noradrenaline (216 ± 11 vs 179 ± 12 nmol/day, p < 0.05) excretion. There was a significant correlation between urinary dopamine and noradrenaline excretion. There was no difference in plasma dopa levels between normotensive and hypertensive subjects. These results suggest that the elevated conversion of dopa to dopamine in the kidney is leading to increased urinary dopamine excretion in young patients with essential hypertension.

AB - The evidence that some older patients with essential hypertension have low urinary dopamine excretion has brought into question the levels of urinary dopamine and plasma dopa, the major source of urinary dopamine, in young patients with essential hypertension. Twentyfour-hour urine sodium, creatinine, dopamine and noradrenaline and plasma dopa were evaluated in 48 patients with essential hypertension aged 18 to 27 years and 25 normotensive subjects. In comparison with age-matched normotensive subjects, the hypertensive patients had higher urinary dopamine (1920 ± 80 vs 1520 ± 130 nmol/day, p < 0.01) and noradrenaline (216 ± 11 vs 179 ± 12 nmol/day, p < 0.05) excretion. There was a significant correlation between urinary dopamine and noradrenaline excretion. There was no difference in plasma dopa levels between normotensive and hypertensive subjects. These results suggest that the elevated conversion of dopa to dopamine in the kidney is leading to increased urinary dopamine excretion in young patients with essential hypertension.

KW - Dopa

KW - Dopamine

KW - Essential Hypertension

UR - http://www.scopus.com/inward/record.url?scp=0028203342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028203342&partnerID=8YFLogxK

U2 - 10.3109/10641969409068582

DO - 10.3109/10641969409068582

M3 - Article

C2 - 8136773

AN - SCOPUS:0028203342

VL - 16

SP - 29

EP - 39

JO - Clinical and Experimental Hypertension

JF - Clinical and Experimental Hypertension

SN - 1064-1963

IS - 1

ER -